TAHOR Side Effects

7020793-7 | Balance Disorder, Confusional State, Muscular Weakness
on Sep 21, 2010 Male patient from FRANCE , 74 years of age, was treated with Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, confusional state, muscular weakness. Tahor dosage: 10 Mg, Unk. Patient was hospitalized.

7020781-0 | Face Oedema
Patient was taking Tahor (View Usage). Patient had the following side effects: face oedema on Sep 23, 2010 from FRANCE Additional patient health information: Male patient , 85 years of age, was diagnosed with prostate cancer (What is prostate cancer?), hypertension, diabetes mellitus and. Tahor dosage: 80 Mg, 1x/day. During the same period patient was treated with GABAPENTIN (100 Mg, 3x/day) (View Gabapentin Review and Gabapentin Label ), DILTIAZEM HYDROCHLORIDE (300 Mg, 1x/day) (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), ESTRACYT (140 Mg, 1x/day) (View Estracyt Review and Estracyt Label ), CAPTOPRIL (50 Mg, 3x/day) (View Captopril Review and Captopril Label ), FLUDEX (1.5 Mg, 1x/day) (View Fludex Review and Fludex Label ), AERIUS (5 Mg, 1x/day) (View Aerius Review and Aerius Label ), GLUCOR (50 Mg, 3x/day) (View Glucor Review and Glucor Label ), NOVONORM (4 Mg, 3x/day) (View Novonorm Review and Novonorm Label ).

7013031-2 | Eosinophilia, Eosinophilic Fasciitis, Hypertension, Hypoalbuminaemia, Proteinuria
Adverse event was reported on Sep 17, 2010 by a Male patient taking Tahor (View Usage) (Dosage: 10 Mg, 1x/day) . Location: FRANCE , 57 years of age, After Tahor was administered, patient had the following side effects: eosinophilia, eosinophilic fasciitis, hypertension, hypoalbuminaemia, proteinuria. During the same period patient was treated with FRACTAL (1 Df, 1x/day) (View Fractal Review and Fractal Label ), OGAST (1 Df, 1x/day) (View Ogast Review and Ogast Label ), NEXIUM (1 Df, 1x/day) (View Nexium Review and Nexium Label ). Patient was hospitalized.

7009698-5 | Blood Creatine Phosphokinase Increased, Hyperlipasaemia, Muscle Spasms, Myalgia, Nausea, Vertigo
on Sep 16, 2010 Male patient from FRANCE , 64 years of age, was diagnosed with hypertriglyceridaemia, hypercholesterolaemia and was treated with Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, hyperlipasaemia, muscle spasms, myalgia, nausea (What is nausea?), vertigo. Tahor dosage: 10 Mg, 1x/day.


7007648-9 | Cytolytic Hepatitis, Renal Failure Acute, Rhabdomyolysis
on Sep 15, 2010 Female patient from FRANCE , 80 years of age, was diagnosed with hypercholesterolaemia, hyperthermia and was treated with Tahor (View Usage). Patient had the following side effects: cytolytic hepatitis, renal failure acute, rhabdomyolysis. Tahor dosage: 20 Mg, 1x/day. During the same period patient was treated with DOLIPRANE (500 Mg, 4df) (View Doliprane Review and Doliprane Label ), PARACETAMOL (1 G, 1x/day) (View Paracetamol Review and Paracetamol Label ), LASIX (20 Mg, 1x/day) (View Lasix Review and Lasix Label ), PREVISCAN (Unk) (View Previscan Review and Previscan Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), SERESTA (Unk) (View Seresta Review and Seresta Label ), BISOPROLOL FUMARATE (Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

7007642-8 | Cytolytic Hepatitis
Patient was taking Tahor (View Usage). After Tahor was administered, patient had the following side effects: cytolytic hepatitis on Sep 14, 2010 from FRANCE Additional patient health information: Female patient , 89 years of age, . Tahor dosage: 80 Mg, 1x/day. During the same period patient was treated with INIPOMP (20 Mg, 1x/day) (View Inipomp Review and Inipomp Label ), PLAVIX (75 Mg, 1x/day) (View Plavix Review and Plavix Label ), METOPROLOL (1 Df, 2x/day) (View Metoprolol Review and Metoprolol Label ), VASTAREL (35 Mg, 2x/day) (View Vastarel Review and Vastarel Label ), KARDEGIC (75 Mg, 1x/day) (View Kardegic Review and Kardegic Label ), PERINDOPRIL ERBUMINE (5 Mg, 1x/day) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), ZOLPIDEM TARTRATE (1 X/day) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), TANAKAN (3 X/ Day) (View Tanakan Review and Tanakan Label ). Patient was hospitalized.

6987176-7 | Vertigo, Vision Blurred, Visual Impairment
Adverse event was reported on Sep 09, 2010 by a Male patient taking Tahor (View Usage) (Dosage: 40 Mg Per Day) was diagnosed with myocardial infarction, coronary artery disease (What is coronary artery disease?), neuralgia, hypersensitivity and. Location: FRANCE , 77 years of age, weighting 187.4 lb, Patient experienced the following unwanted or unexpected effects: vertigo, vision blurred, visual impairment. During the same period patient was treated with KARDEGIC (75 Mg, 1x/day) (View Kardegic Review and Kardegic Label ), BISOPROLOL FUMARATE (5 Mg, 1x/day) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), INSPRA (25 Mg, 1x/day) (View Inspra Review and Inspra Label ), LYRICA (150 Mg, Two Tablets Per Day) (View Lyrica Review and Lyrica Label ), XYZAL (5 Mg, 1x/day) (View Xyzal Review and Xyzal Label ).

6984617-6 | Haematuria
on Sep 07, 2010 Male patient from FRANCE , 75 years of age, was diagnosed with prophylaxis, aortic valve replacement, cardiac failure, hypertension, iron deficiency, anxiety (What is anxiety?) and was treated with Tahor (View Usage). Patient had the following side effects: haematuria. Tahor dosage: 40 Mg, 1x/day. During the same period patient was treated with PREVISCAN (0.5 Df/0.25 Df In Alternate Day) (View Previscan Review and Previscan Label ), ALDACTONE (25 Mg, 1x/day) (View Aldactone Review and Aldactone Label ), TRIATEC (1.25 Mg, 1x/day) (View Triatec Review and Triatec Label ), TARDYFERON (80 Mg, 3x/day) (View Tardyferon Review and Tardyferon Label ), LASIX (250 Mg, 1x/day) (View Lasix Review and Lasix Label ), HEMIGOXINE NATIVELLE (1 Df, 1x/day) (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), ATARAX (25 Mg, 1x/day) (View Atarax Review and Atarax Label ). Patient was hospitalized.

6984592-4 | Thrombocytopenia
on Sep 07, 2010 Male patient from FRANCE , 83 years of age, was treated with Tahor (View Usage). After Tahor was administered, patient had the following side effects: thrombocytopenia. Tahor dosage: 10 Mg, 1x/day. During the same period patient was treated with ENALAPRIL MALEATE (2.5 Mg, 1x/day) (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

6976898-X | Paraesthesia
Patient was taking Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: paraesthesia on Sep 01, 2010 from FRANCE Additional patient health information: Male patient , 40 years of age, . Tahor dosage: Unk.

6967589-X | High Density Lipoprotein Decreased
Adverse event was reported on Aug 30, 2010 by a Female patient taking Tahor (View Usage) (Dosage: 10 Mg, 1x/day) was diagnosed with hypercholesterolaemia and. Location: SENEGAL , 35 years of age, weighting 154.3 lb, Patient had the following side effects: high density lipoprotein decreased.

6967580-3 | Dyspnoea, Muscular Weakness, Rhabdomyolysis
on Aug 31, 2010 Male patient from SWITZERLAND , 64 years of age, was diagnosed with dyslipidaemia and was treated with Tahor (View Usage). After Tahor was administered, patient had the following side effects: dyspnoea, muscular weakness, rhabdomyolysis. Tahor dosage: 20 Mg, 1x/day. During the same period patient was treated with METFORMIN HYDROCHLORIDE (850 Mg, 3x/day) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), LEXOMIL (Unk) (View Lexomil Review and Lexomil Label ).

6965510-1 | Bradycardia
on Aug 26, 2010 Female patient from FRANCE , 82 years of age, was diagnosed with dementia alzheimer's type, myocardial ischaemia and was treated with Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia. Tahor dosage: Unk. During the same period patient was treated with ARICEPT (Unk) (View Aricept Review and Aricept Label ), BISOPROLOL FUMARATE (Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), TRIATEC (Unk) (View Triatec Review and Triatec Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6964419-7 | Rhabdomyolysis, Weight Decreased
Patient was taking Tahor (View Usage). Patient had the following side effects: rhabdomyolysis, weight decreased on Aug 25, 2010 from FRANCE Additional patient health information: Male patient , 64 years of age, weighting 166.4 lb, was diagnosed with hypercholesterolaemia and. Tahor dosage: 20 Mg, 1x/day.

6962619-3 | Hepatic Steatosis, Pancreatitis
Adverse event was reported on Aug 26, 2010 by a Male patient taking Tahor (View Usage) (Dosage: 20 Mg, 1x/day) . Location: FRANCE , 64 years of age, After Tahor was administered, patient had the following side effects: hepatic steatosis, pancreatitis. During the same period patient was treated with SITAGLIPTIN (100 Mg, 1x/day) (View Sitagliptin Review and Sitagliptin Label ), GLUCOR (100 Mg, 3x/day) (View Glucor Review and Glucor Label ), LOXEN (Unk) (View Loxen Review and Loxen Label ), FORTZAAR ([losartan 100]/[hydrochlorothiazide 25], Unk) (View Fortzaar Review and Fortzaar Label ), DIAMICRON (30mg, Unk) (View Diamicron Review and Diamicron Label ). Patient was hospitalized.

6960584-6 | Cholestasis, Cytolytic Hepatitis
on Aug 23, 2010 Female patient from FRANCE , 78 years of age, weighting 130.1 lb, was diagnosed with low density lipoprotein increased, cerebrovascular accident and was treated with Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, cytolytic hepatitis. Tahor dosage: 80 Mg, 1x/day. Patient was hospitalized.

6944521-6 | Arthralgia, C-reactive Protein Increased, Diarrhoea, Hiccups, Myalgia, Urticaria
on Aug 17, 2010 Male patient from FRANCE , 50 years of age, was diagnosed with myocardial infarction and was treated with Tahor (View Usage). Patient had the following side effects: arthralgia, c-reactive protein increased, diarrhoea, hiccups, myalgia, urticaria. Tahor dosage: 80 Mg, 1x/day. Patient was hospitalized.

6941796-4 | Activated Partial Thromboplastin Time Prolonged
Patient was taking Tahor (View Usage). After Tahor was administered, patient had the following side effects: activated partial thromboplastin time prolonged on Aug 18, 2010 from FRANCE Additional patient health information: Male patient , 66 years of age, was diagnosed with hypercholesterolaemia, thrombosis prophylaxis, pain (What is pain?), cardiovascular event prophylaxis and. Tahor dosage: 10 Mg, 1x/day. During the same period patient was treated with PRADAXA (2 Df Per Day) (View Pradaxa Review and Pradaxa Label ), FUMAFER (3 Df Per Day) (View Fumafer Review and Fumafer Label ), IXPRIM (6 Df Max Per Day) (View Ixprim Review and Ixprim Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), DILTIAZEM HCL (Unk) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), EZETROL (10 Mg, 1x/day) (View Ezetrol Review and Ezetrol Label ). Patient was hospitalized.

6939955-X | Cytolytic Hepatitis
Adverse event was reported on Aug 17, 2010 by a Female patient taking Tahor (View Usage) (Dosage: Unk) . Location: FRANCE , 64 years of age, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. During the same period patient was treated with CRESTOR (Unk) (View Crestor Review and Crestor Label ), EFFIENT (Unk) (View Effient Review and Effient Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), RANITIDINE HCL (Unk) (View Ranitidine Hcl Review and Ranitidine Hcl Label ), BISOPROLOL FUMARATE (Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), MICARDIS (Unk) (View Micardis Review and Micardis Label ). Patient was hospitalized.

6934082-X | Urinary Retention
on Aug 12, 2010 Female patient from FRANCE , 81 years of age, was treated with Tahor (View Usage). Patient had the following side effects: urinary retention. Tahor dosage: 10 Mg, Unk. During the same period patient was treated with CANDESARTAN CILEXETIL/HYDROCHLOROTHIAZIDE (ATACAND HCT) (Unk) (View Candesartan Cilexetil/hydrochlorothiazide (atacand Hct) Review and Candesartan Cilexetil/hydrochlorothiazide (atacand Hct) Label ).

6924947-7 | Cytolytic Hepatitis, Leukopenia
on Aug 06, 2010 Female patient from FRANCE , 64 years of age, was treated with Tahor (View Usage). After Tahor was administered, patient had the following side effects: cytolytic hepatitis, leukopenia. Tahor dosage: Unk. During the same period patient was treated with CRESTOR (Unk) (View Crestor Review and Crestor Label ), EFFIENT (Unk) (View Effient Review and Effient Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), RANITIDINE HCL (Unk) (View Ranitidine Hcl Review and Ranitidine Hcl Label ), BISOPROLOL FUMARATE (Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), MICARDIS (Unk) (View Micardis Review and Micardis Label ). Patient was hospitalized.

6921816-3 | Arthralgia, Myalgia, Sleep Disorder
Patient was taking Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, myalgia, sleep disorder (What is sleep disorder?) on Aug 03, 2010 from FRANCE Additional patient health information: Male patient , 65 years of age, weighting 198.0 lb, was diagnosed with hypercholesterolaemia and. Tahor dosage: 20 Mg, 1x/day. During the same period patient was treated with TENORMIN (Unk) (View Tenormin Review and Tenormin Label ), VASTAREL (35, Unk) (View Vastarel Review and Vastarel Label ).

6921036-2 | Liver Injury
Adverse event was reported on Aug 05, 2010 by a Male patient taking Tahor (View Usage) (Dosage: 10 Mg, 1x/day) was diagnosed with cardiac failure and. Location: FRANCE , 71 years of age, Patient had the following side effects: liver injury. During the same period patient was treated with BISOPROLOL FUMARATE (3.75 Mg, 1x/day) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ), LASIX (10 Mg, 1x/day) (View Lasix Review and Lasix Label ), LEVOTHYROXINE SODIUM (100 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), COMBIVENT (Unk) (View Combivent Review and Combivent Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), CALCIPARINE (Unk) (View Calciparine Review and Calciparine Label ), IMOVANE (Unk) (View Imovane Review and Imovane Label ). Patient was hospitalized.

6921032-5 | Pancreatitis Acute
on Aug 05, 2010 Male patient from FRANCE , 75 years of age, was treated with Tahor (View Usage). After Tahor was administered, patient had the following side effects: pancreatitis acute. Tahor dosage: 1 Df, 1x/day. During the same period patient was treated with INSULIN DETEMIR (Unk) (View Insulin Detemir Review and Insulin Detemir Label ), NOVONORM (Unk) (View Novonorm Review and Novonorm Label ), COAPROVEL (Unk) (View Coaprovel Review and Coaprovel Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), GLUCOPHAGE (Unk) (View Glucophage Review and Glucophage Label ), PIASCLEDINE (Unk) (View Piascledine Review and Piascledine Label ), LOPERAMIDE HYDROCHLORIDE (Unk) (View Loperamide Hydrochloride Review and Loperamide Hydrochloride Label ). Patient was hospitalized.

6919178-0 | Acute Respiratory Failure, Asthenia, Dysuria, Gait Disturbance, Motor Dysfunction, Myalgia, Polymyositis, Respiratory Disorder, Rhabdomyolysis
on Aug 02, 2010 Female patient from FRANCE , 62 years of age, weighting 180.8 lb, was diagnosed with blood cholesterol, thrombosis prophylaxis, hypertension, depression (What is depression?), muscle spasms, vertigo and was treated with Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, asthenia, dysuria, gait disturbance, motor dysfunction, myalgia, polymyositis, respiratory disorder, rhabdomyolysis. Tahor dosage: 10 Mg, 1x/day (in The Evening). During the same period patient was treated with ATENOLOL (100 Unk, 1x/day (in The Morning)) (View Atenolol Review and Atenolol Label ), EFFEXOR (37.5 Mg, Unk) (View Effexor Review and Effexor Label ), ATEPADENE (30 Mg, 1x/day) (View Atepadene Review and Atepadene Label ), TANGANIL (2 Df, 1x/day (in The Morning)) (View Tanganil Review and Tanganil Label ). Patient was hospitalized and became disabled.

6918794-X | Henoch-schonlein Purpura, Leukocytoclastic Vasculitis
Patient was taking Tahor (View Usage). Patient had the following side effects: henoch-schonlein purpura, leukocytoclastic vasculitis on Aug 05, 2010 from FRANCE Additional patient health information: Female patient , 76 years of age, . Tahor dosage: 40 Mg, 1x/day. During the same period patient was treated with IXPRIM (Unk) (View Ixprim Review and Ixprim Label ), LASIX (20 Mg, 1x/day) (View Lasix Review and Lasix Label ), ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

6918656-8 | Gait Disturbance, Myalgia, Peripheral Sensory Neuropathy
Adverse event was reported on Aug 03, 2010 by a Female patient taking Tahor (View Usage) (Dosage: Unk) was diagnosed with dyslipidaemia and. Location: FRANCE , 69 years of age, After Tahor was administered, patient had the following side effects: gait disturbance, myalgia, peripheral sensory neuropathy. During the same period patient was treated with FENOFIBRATE (Unk) (View Fenofibrate Review and Fenofibrate Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), EZETROL (10 Mg, Unk) (View Ezetrol Review and Ezetrol Label ). Patient was hospitalized.

6908560-3 | Erectile Dysfunction
on Jul 29, 2010 Male patient from FRANCE , 40 years of age, weighting 147.7 lb, was diagnosed with type iia hyperlipidaemia and was treated with Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: erectile dysfunction (What is erectile dysfunction?). Tahor dosage: 40 Mg, Unk.

6908550-0 | Dermatomyositis
on Jul 28, 2010 Female patient from FRANCE , 80 years of age, was treated with Tahor (View Usage). Patient had the following side effects: dermatomyositis. Tahor dosage: 1 Df, Per Day. During the same period patient was treated with COAPROVEL (Unk) (View Coaprovel Review and Coaprovel Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), FOSAVANCE (Unk) (View Fosavance Review and Fosavance Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6908546-9 | Eyelid Oedema, Oedema Peripheral
Patient was taking Tahor (View Usage). After Tahor was administered, patient had the following side effects: eyelid oedema, oedema peripheral on Jul 28, 2010 from FRANCE Additional patient health information: Female patient , 49 years of age, . Tahor dosage: 10 Mg, 1x/day.

6895783-5 | Paraesthesia
Adverse event was reported on Jul 23, 2010 by a Male patient taking Tahor (View Usage) (Dosage: Unk) . Location: FRANCE , 40 years of age, Patient experienced the following unwanted or unexpected effects: paraesthesia.

6888108-2 | Thrombotic Thrombocytopenic Purpura
on Jul 22, 2010 Male patient from FRANCE , 75 years of age, was treated with Tahor (View Usage). Patient had the following side effects: thrombotic thrombocytopenic purpura. Tahor dosage: . During the same period patient was treated with PLAVIX (Unk) (View Plavix Review and Plavix Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), HUMALOG (View Humalog Review and Humalog Label ). Patient was hospitalized.

6888101-X | Hypoaesthesia, Pain In Extremity
on Jul 22, 2010 Male patient from FRANCE , 55 years of age, was diagnosed with hypercholesterolaemia, hypertension, erdheim-chester disease, pain (What is pain?) and was treated with Tahor (View Usage). After Tahor was administered, patient had the following side effects: hypoaesthesia, pain in extremity. Tahor dosage: Unk. During the same period patient was treated with ESIDRIX (Unk) (View Esidrix Review and Esidrix Label ), KINERET (Unk) (View Kineret Review and Kineret Label ), RAMIPRIL (Unk) (View Ramipril Review and Ramipril Label ), TOPALGIC (Unk) (View Topalgic Review and Topalgic Label ), MEDIATENSYL (Unk) (View Mediatensyl Review and Mediatensyl Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), ASPEGIC 1000 (Unk) (View Aspegic 1000 Review and Aspegic 1000 Label ), KAYEXALATE (Unk) (View Kayexalate Review and Kayexalate Label ).

6878309-1 | Cerebral Haematoma, Epilepsy
Patient was taking Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haematoma, epilepsy (What is epilepsy?) on Jul 19, 2010 from FRANCE Additional patient health information: Female patient , 56 years of age, . Tahor dosage: Unk. During the same period patient was treated with COUMADIN (Unk) (View Coumadin Review and Coumadin Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), RAMIPRIL (Unk) (View Ramipril Review and Ramipril Label ), PANTOPRAZOLE SODIUM (Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

6878228-0 | Cholestasis, Mixed Liver Injury, Pyrexia
Adverse event was reported on Jul 19, 2010 by a Male patient taking Tahor (View Usage) (Dosage: 80 Mg, 1x/day) was diagnosed with cerebrovascular accident prophylaxis, gastrooesophageal reflux disease, hypertension, insomnia and. Location: FRANCE , 55 years of age, weighting 119.0 lb, Patient had the following side effects: cholestasis, mixed liver injury, pyrexia. During the same period patient was treated with NEXIUM (20 Mg, 1x/day) (View Nexium Review and Nexium Label ), PERINDOPRIL ERBUMINE (4 Mg, 1x/day) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), INDAPAMIDE (1.5 Mg, 1x/day) (View Indapamide Review and Indapamide Label ), IMOVANE (7.5 Mg, 1x/day) (View Imovane Review and Imovane Label ). Patient was hospitalized.

6875686-2 | Pancreatitis Acute
on Jul 19, 2010 Male patient from FRANCE , 48 years of age, was diagnosed with hypercholesterolaemia and was treated with Tahor (View Usage). After Tahor was administered, patient had the following side effects: pancreatitis acute. Tahor dosage: 10 Mg, 1x/day. Patient was hospitalized.

6868346-5 | Asthenia, Balance Disorder, Fall, Paralysis, Vertigo
on Jul 01, 2010 Male patient from FRANCE , 92 years of age, weighting 154.3 lb, was diagnosed with myocardial ischaemia, cardiac disorder and was treated with Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, balance disorder, fall (What is fall?), paralysis (What is paralysis?), vertigo. Tahor dosage: 10 Mg, 1x/day. During the same period patient was treated with SECTRAL (1 Df, 1x/day) (View Sectral Review and Sectral Label ), KARDEGIC (1 Df, 1x/day) (View Kardegic Review and Kardegic Label ).

6863486-9 | Muscle Rupture, Myalgia, Tendon Rupture, Tendonitis
Patient was taking Tahor (View Usage). Patient had the following side effects: muscle rupture, myalgia, tendon rupture, tendonitis on Jul 07, 2010 from FRANCE Additional patient health information: Female patient , 63 years of age, weighting 130.0 lb, was diagnosed with hypercholesterolaemia, thyroid disorder, osteopenia and. Tahor dosage: 20 Mg, 1x/day. During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Unk, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), UVEDOSE (View Uvedose Review and Uvedose Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ).

6857201-2 | Blood Creatine Phosphokinase Increased, Fatigue, Malaise, Pain, Rhabdomyolysis
Adverse event was reported on Jul 09, 2010 by a Male patient taking Tahor (View Usage) (Dosage: 10) . Location: FRANCE , 50 years of age, After Tahor was administered, patient had the following side effects: blood creatine phosphokinase increased, fatigue, malaise, pain (What is pain?), rhabdomyolysis.

6856580-X | Dyspnoea, Malaise
on Jul 12, 2010 Male patient from FRANCE , 74 years of age, was diagnosed with hypercholesterolaemia and was treated with Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, malaise. Tahor dosage: 10 Mg, Unk. During the same period patient was treated with KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), FLECAINIDE ACETATE (Unk) (View Flecainide Acetate Review and Flecainide Acetate Label ), OLMETEC (Unk) (View Olmetec Review and Olmetec Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ).

6831860-2 | Fall
on Jul 02, 2010 Male patient from FRANCE , 81 years of age, was treated with Tahor (View Usage). Patient had the following side effects: fall (What is fall?). Tahor dosage: 40 Mg, 2x/day. During the same period patient was treated with TRIMEBUTINE (1 Df, 2x/day) (View Trimebutine Review and Trimebutine Label ), NOCERTONE (60 Mg, 3x/day) (View Nocertone Review and Nocertone Label ), SEGLOR (1 Df, 2x/day) (View Seglor Review and Seglor Label ), BISOPROLOL (1 Df, 2x/day) (View Bisoprolol Review and Bisoprolol Label ), BI PROFENID (150 Mg, 2x/day) (View Bi-profenid Review and Bi-profenid Label ), SKENAN (30 Mg, 2x/day) (View Skenan Review and Skenan Label ), GLYBURIDE (5 Mg, 2x/day) (View Glyburide Review and Glyburide Label ), SINTROM (1 Df, Dose Unchanged) (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

6831858-4 | Cholestasis, Mixed Liver Injury, Pyrexia
Patient was taking Tahor (View Usage). After Tahor was administered, patient had the following side effects: cholestasis, mixed liver injury, pyrexia on Jul 02, 2010 from FRANCE Additional patient health information: Male patient , 55 years of age, weighting 119.0 lb, was diagnosed with cerebrovascular accident prophylaxis, gastrooesophageal reflux disease, hypertension, insomnia and. Tahor dosage: 80 Mg, 1x/day. During the same period patient was treated with NEXIUM (20 Mg, 1x/day) (View Nexium Review and Nexium Label ), COVERSYL (4 Mg, 1x/day) (View Coversyl Review and Coversyl Label ), INDAPAMIDE (1.5 Mg, 1x/day) (View Indapamide Review and Indapamide Label ), IMOVANE (7.5 Mg, 1x/day) (View Imovane Review and Imovane Label ). Patient was hospitalized.

6831854-7 | Cytolytic Hepatitis, Renal Failure Chronic, Rhabdomyolysis, Somnolence
Adverse event was reported on Jul 02, 2010 by a Female patient taking Tahor (View Usage) (Dosage: 40 Mg, Unk) was diagnosed with dyslipidaemia, herpes zoster, renal transplant, osteoporosis (What is osteoporosis?) and. Location: FRANCE , 60 years of age, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, renal failure chronic, rhabdomyolysis, somnolence. During the same period patient was treated with ZELITREX (3 G, Daily) (View Zelitrex Review and Zelitrex Label ), NEORAL (70 Mg, 2x/day) (View Neoral Review and Neoral Label ), TRIATEC (5 Mg, Daily) (View Triatec Review and Triatec Label ), FOSAMAX (70 Mg, Weekly) (View Fosamax Review and Fosamax Label ), CORTANCYL (10 Mg, 1x/day) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6826638-X | Asthenia, Balance Disorder, Fall, Paralysis, Vertigo
on Jul 01, 2010 Male patient from FRANCE , 92 years of age, weighting 154.3 lb, was diagnosed with myocardial ischaemia, cardiac disorder and was treated with Tahor (View Usage). Patient had the following side effects: asthenia, balance disorder, fall (What is fall?), paralysis (What is paralysis?), vertigo. Tahor dosage: 10 Mg, 1x/day. During the same period patient was treated with SECTRAL (1 Df, 1x/day) (View Sectral Review and Sectral Label ), KARDEGIC (1 Df, 1x/day) (View Kardegic Review and Kardegic Label ).

6820215-2 | Pulmonary Fibrosis
on Jun 28, 2010 Female patient from FRANCE , 76 years of age, was diagnosed with hypertension and was treated with Tahor (View Usage). After Tahor was administered, patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?). Tahor dosage: Unk. During the same period patient was treated with METHOTREXATE SODIUM (12.5 Mg, Weekly) (View Methotrexate Sodium Review and Methotrexate Sodium Label ), TAREG (80 Mg, Daily) (View Tareg Review and Tareg Label ), KARDEGIC (75 Mg, Daily) (View Kardegic Review and Kardegic Label ), INSULIN DETEMIR (LEVEMIR) (28 Iu, Daily) (View Insulin Detemir (levemir) Review and Insulin Detemir (levemir) Label ), NOVORAPID (30 Iu, Daily) (View Novorapid Review and Novorapid Label ), SECTRAL (200 Mg, Daily) (View Sectral Review and Sectral Label ). Patient was hospitalized and became disabled.

6818140-6 | Autoimmune Hepatitis
Patient was taking Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune hepatitis on Jun 28, 2010 from FRANCE Additional patient health information: Female patient , 46 years of age, was diagnosed with dyslipidaemia and. Tahor dosage: 20 Mg, Unk. During the same period patient was treated with LUTENYL (View Lutenyl Review and Lutenyl Label ), ESTREVA (View Estreva Review and Estreva Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6818109-1 | Blood Creatinine Increased, Cytolytic Hepatitis, Rhabdomyolysis
Adverse event was reported on Jun 28, 2010 by a Male patient taking Tahor (View Usage) (Dosage: 40 Mg, 1x/day) . Location: FRANCE , 81 years of age, Patient had the following side effects: blood creatinine increased, cytolytic hepatitis, rhabdomyolysis. During the same period patient was treated with TRIATEC (2.5 Mg, 1x/day) (View Triatec Review and Triatec Label ), PRASUGREL (Unk) (View Prasugrel Review and Prasugrel Label ). Patient was hospitalized.

6817809-7 | Acquired Haemophilia
on Jun 28, 2010 Male patient from FRANCE , 69 years of age, weighting 227.0 lb, was treated with Tahor (View Usage). After Tahor was administered, patient had the following side effects: acquired haemophilia. Tahor dosage: 20 Mg, 1x/day. During the same period patient was treated with LYRICA (Unk) (View Lyrica Review and Lyrica Label ), ISOPTIN (240 Mg, 1x/day) (View Isoptin Review and Isoptin Label ), VASTAREL (35 Mg, 2x/day) (View Vastarel Review and Vastarel Label ), CITALOPRAM HYDROBROMIDE (20 Mg, 1x/day) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ASPEGIC 1000 (Unk) (View Aspegic 1000 Review and Aspegic 1000 Label ), DIFFU K (View Diffu K Review and Diffu K Label ), LASILIX 40 (View Lasilix 40 Review and Lasilix 40 Label ), CORTANCYL 20 (View Cortancyl 20 Review and Cortancyl 20 Label ). Patient was hospitalized.

6813406-8 | Myoclonus
on Jun 23, 2010 Male patient from FRANCE , 58 years of age, weighting 172.0 lb, was diagnosed with cerebrovascular accident and was treated with Tahor (View Usage). Patient experienced the following unwanted or unexpected effects: myoclonus. Tahor dosage: 80 Mg, Unk. During the same period patient was treated with COVERSYL (10 Mg, 1x/day) (View Coversyl Review and Coversyl Label ), PLAVIX (75 Mg, 1x/day) (View Plavix Review and Plavix Label ), NEBILOX (5 Mg, 1x/day) (View Nebilox Review and Nebilox Label ), KARDEGIC (75 Mg, 1x/day) (View Kardegic Review and Kardegic Label ).

6809689-0 | Renal Failure, Respiratory Acidosis, Rhabdomyolysis
Patient was taking Tahor (View Usage). Patient had the following side effects: renal failure, respiratory acidosis, rhabdomyolysis on Jun 22, 2010 from FRANCE Additional patient health information: Male patient , 68 years of age, . Tahor dosage: 80 Mg, 1x/day. During the same period patient was treated with FUCIDINE (500 Mg, 3x/day) (View Fucidine Review and Fucidine Label ), OFLOCET (200 Mg, 2x/day) (View Oflocet Review and Oflocet Label ), NEXIUM (20 Mg, 1x/day) (View Nexium Review and Nexium Label ), CARDENSIEL (1.25 Mg, 1x/day) (View Cardensiel Review and Cardensiel Label ), KARDEGIC (75 Mg, 1x/day) (View Kardegic Review and Kardegic Label ), CALCIPARINE (1 Df, 2x/day) (View Calciparine Review and Calciparine Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.